WO2011043564A3 - Composition contenant des extraits de ginseng noir pour prévention ou traitement du cancer du foie - Google Patents

Composition contenant des extraits de ginseng noir pour prévention ou traitement du cancer du foie Download PDF

Info

Publication number
WO2011043564A3
WO2011043564A3 PCT/KR2010/006744 KR2010006744W WO2011043564A3 WO 2011043564 A3 WO2011043564 A3 WO 2011043564A3 KR 2010006744 W KR2010006744 W KR 2010006744W WO 2011043564 A3 WO2011043564 A3 WO 2011043564A3
Authority
WO
WIPO (PCT)
Prior art keywords
black ginseng
liver cancer
preventing
composition containing
treating liver
Prior art date
Application number
PCT/KR2010/006744
Other languages
English (en)
Korean (ko)
Other versions
WO2011043564A2 (fr
Inventor
김항종
Original Assignee
Kim Hang Jong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kim Hang Jong filed Critical Kim Hang Jong
Priority to CN2010800554591A priority Critical patent/CN102711779A/zh
Publication of WO2011043564A2 publication Critical patent/WO2011043564A2/fr
Publication of WO2011043564A3 publication Critical patent/WO2011043564A3/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne un procédé destiné à augmenter de manière spécifique les ingrédients Rg3 à partir d'ingrédients ginsenosides de ginseng noir. Les extraits de ginseng noir préparés par le procédé montrent une activité anticancéreuse élevée contre les cellules humaines de cancer du foie. En outre, il a été vérifié que le procédé de la présente invention a pour effet de diminuer la teneur en benzopyrène, connue comme étant principalement générée lors du chauffage.
PCT/KR2010/006744 2009-10-07 2010-10-04 Composition contenant des extraits de ginseng noir pour prévention ou traitement du cancer du foie WO2011043564A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010800554591A CN102711779A (zh) 2009-10-07 2010-10-04 用于预防或治疗肝癌的包含乌参提取物的组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2009-0095003 2009-10-07
KR1020090095003A KR100972941B1 (ko) 2009-10-07 2009-10-07 흑삼 추출물을 함유하는 간암 예방 또는 치료용 조성물

Publications (2)

Publication Number Publication Date
WO2011043564A2 WO2011043564A2 (fr) 2011-04-14
WO2011043564A3 true WO2011043564A3 (fr) 2011-09-01

Family

ID=42646131

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/006744 WO2011043564A2 (fr) 2009-10-07 2010-10-04 Composition contenant des extraits de ginseng noir pour prévention ou traitement du cancer du foie

Country Status (3)

Country Link
KR (1) KR100972941B1 (fr)
CN (1) CN102711779A (fr)
WO (1) WO2011043564A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101369638B1 (ko) 2012-01-04 2014-03-06 주식회사 한국인삼공사 동체 균열이 억제된 홍삼의 제조방법
CN104873558A (zh) * 2015-06-11 2015-09-02 北京凯宾鸿生物医药科技有限公司 一种高含量人参皂苷的黑参的制备方法
CN107737146B (zh) * 2017-11-21 2021-04-02 扬州大学 竹节参片及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030005089A (ko) * 2002-11-15 2003-01-15 김항종 흑삼과 흑미삼의 제조방법
KR100600795B1 (ko) * 2006-01-18 2006-07-19 (주) 흑삼코리아 진세노사이드 알지쓰리 성분의 함량이 뛰어난 흑삼 및 흑삼농축액
KR100692294B1 (ko) * 2006-08-31 2007-03-12 박춘자 대장암에 대해 항암효과가 뛰어난 흑삼추출물의 제조방법
KR100729214B1 (ko) * 2006-11-07 2007-06-19 (주)고려바이오홍삼 흑삼의 제조방법과 이를 이용하여 제조된 흑삼
KR100754253B1 (ko) * 2006-05-17 2007-09-03 충남대학교산학협력단 신규한 흑삼의 제조방법 및 이를 함유하는 조성물
KR20080106077A (ko) * 2007-05-31 2008-12-04 박용진 신규한 흑홍삼 및 이의 추출물의 제조방법 및 이를함유하는 조성물
KR20090093310A (ko) * 2008-02-29 2009-09-02 강신정 벤조피렌이 저감된 홍삼 및 흑삼의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101127279B1 (ko) * 2006-08-11 2012-03-29 박용진 신규제조방법으로 제조된 흑인삼엽 및 이의 추출물을함유하는 항산화용 조성물
WO2008075866A1 (fr) * 2006-12-18 2008-06-26 Yong Jin Park Composition contenant un extrait transformé de panax quinquefolium l. pour la prévention et le traitement du cancer
CN101278954A (zh) * 2007-04-04 2008-10-08 赵方林 一种增加了人参皂苷Rg3含量的人参或西洋参制品及其制备方法
KR100920661B1 (ko) * 2007-10-23 2009-10-08 한국한방식품공사주식회사 사포닌 함량이 높은 흑삼 및 그 제조방법.
KR20090095354A (ko) * 2008-03-05 2009-09-09 주식회사 엔유씨전자 흑삼제조기 및 이를 이용한 흑삼제조방법

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030005089A (ko) * 2002-11-15 2003-01-15 김항종 흑삼과 흑미삼의 제조방법
KR100600795B1 (ko) * 2006-01-18 2006-07-19 (주) 흑삼코리아 진세노사이드 알지쓰리 성분의 함량이 뛰어난 흑삼 및 흑삼농축액
KR100754253B1 (ko) * 2006-05-17 2007-09-03 충남대학교산학협력단 신규한 흑삼의 제조방법 및 이를 함유하는 조성물
KR100692294B1 (ko) * 2006-08-31 2007-03-12 박춘자 대장암에 대해 항암효과가 뛰어난 흑삼추출물의 제조방법
KR100729214B1 (ko) * 2006-11-07 2007-06-19 (주)고려바이오홍삼 흑삼의 제조방법과 이를 이용하여 제조된 흑삼
KR20080106077A (ko) * 2007-05-31 2008-12-04 박용진 신규한 흑홍삼 및 이의 추출물의 제조방법 및 이를함유하는 조성물
KR20090093310A (ko) * 2008-02-29 2009-09-02 강신정 벤조피렌이 저감된 홍삼 및 흑삼의 제조방법

Also Published As

Publication number Publication date
KR100972941B1 (ko) 2010-07-29
WO2011043564A2 (fr) 2011-04-14
CN102711779A (zh) 2012-10-03

Similar Documents

Publication Publication Date Title
WO2009125964A3 (fr) Composition comprenant un polysaccharide extrait de panax ginseng destinée à la prévention et au traitement de maladies hépatiques
WO2011082273A3 (fr) Composés de pyrroloaminopyrimidine substitués
WO2011082270A3 (fr) Composés imidazopyridinyl-aminopyridine substitués
WO2011082267A3 (fr) Composés triazolo-pyrazine substitués
WO2008097640A8 (fr) Composés à base de triazole modulant l'activité de hsp90
WO2009129246A3 (fr) Compositions et leurs procédés de préparation et d'utilisation
WO2011037643A3 (fr) Compositions et procédés de détection et de traitement de carcinomes de la prostate
WO2007139967A3 (fr) Composés de triazole modulant l'activité de hsp90
WO2007139955A3 (fr) Composés de triazole qui modulent l'activité de la hsp90
WO2007139968A3 (fr) Composés de triazole qui modulent l'activité de la hsp90
WO2011146879A3 (fr) Procédés et compositions liés à la modulation de l'autophagie
WO2006037024A3 (fr) Sels de decitabine
WO2006034154A3 (fr) Sels de 5-azacytidine
MX2011006959A (es) Compuestos substituidos de 5,6-dihidro-6-fenilbenzo [f] isoquinolina-2-amina.
WO2009032888A3 (fr) Compositions s'administrant par voie orale, produits et procédés d'utilisation
WO2010017541A3 (fr) Compositions et procédés de traitement d'une maladie dégénérative du système nerveux
WO2007109279A3 (fr) Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation
WO2008105852A3 (fr) Nanoparticules mucoadhésives pour traitement anticancéreux
WO2011123678A3 (fr) Composés de benzo-pyrido-triazolo-diazépine substitués
WO2011129936A3 (fr) Compositions et procédés pour la prévention et le traitement du cancer
EP2353603A4 (fr) Composition pour la prévention ou le traitement du cancer contenant comme principe actif une lignée cellulaire de cellules souches végétales extraite du panax ginseng incluant le ginseng sauvage ou le ginseng
WO2011075822A8 (fr) Compositions immunogènes et méthodes correspondantes
EP2335712A4 (fr) Composition pour la prevention ou le traitement de maladies du foie, contenant des ligneés de cellules souches végétales derivées du cambium de panax ginseng comprenant du ginseng de montagne ou du ginseng comme principe actif
EP2139506A4 (fr) Composition à base de rehmanniae radix preparata, de notoginseng radix, ou de certains de leurs extraits et mélanges, pour la prévention et le traitement de la périodontite
WO2011043564A3 (fr) Composition contenant des extraits de ginseng noir pour prévention ou traitement du cancer du foie

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080055459.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10822209

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10822209

Country of ref document: EP

Kind code of ref document: A2